PDF
(Download)
|
- Turmeric (Curcuma longa)
- Curcuminoids
- Acute Myocardial Infarction
| Date:
06-15-2012 | HC# 051251-450
|
Re: Study Evaluated Effects of Curcuminoids on Acute Myocardial Infarction
Wongcharoen
W, Jai-aue S, Phrommintikul A, et al. Effects of curcuminoids on frequency of
acute myocardial infarction after coronary artery bypass grafting. Am J Cardiol. April 3, 2012;[epub ahead
of print]. doi: 10.1016/j.amjcard.2012.02.043.
Curcuminoids,
polyphenols from turmeric (Curcuma longa),
have anti-inflammatory, antioxidant, and membrane-stabilizing effects. These effects
may be beneficial in treating cardiovascular disease. Specifically, studies
show that curcuminoids decrease proinflammatory cytokines, apoptosis
(programmed cell death), and necrosis (cell death) in animal models during
cardiopulmonary bypass surgery and after ischemia/reperfusion injury. Hence,
the purpose of this randomized, double-blind, placebo-controlled study was to
evaluate the effect of curcuminoids in limiting myocardial ischemia/reperfusion
injury after coronary artery bypass grafting (CABG). Specifically, the study
evaluated whether curcuminoids prevent myocardial infarction (MI) after CABG
compared with placebo.
The study included
consecutive patients (n = 121) undergoing CABG without valve surgery from
September 2009 to December 2011 at Maharaj Nakorn Chiang Mai Hospital, Chiang
Mai University; Chiang Mai, Thailand. Patients were excluded if they needed
emergency cardiac surgery, had an increase in creatine kinase-MB above the
upper limit of the normal range at time of randomization, had cholesteric
jaundice (total bilirubin higher than 2-fold the upper normal limit), or had severe
liver disease (aspartate aminotransferase or alanine aminotransferase higher
than 3-fold the upper normal limit).
Beginning 3 days
before the scheduled surgery, patients received placebo or 4 g/day curcuminoids
(provided by the Research and Development Institute, the Government
Pharmaceutical Organization; Bangkok, Thailand), in addition to standard
therapy. The assigned treatment was continued for 5 days after surgery. Each curcuminoid
capsule (4 capsules taken 4 times/day) contained 250 mg curcuminoids, which
consisted of curcumin, demethoxycurcumin, and bisdemethoxycurcumin in a ratio
of 1.0:0.6:0.3. Surgical technique was at the discretion of the surgeon.
Twelve-lead electrocardiograms, serial creatine kinase-MB levels, and
N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels were recorded. In
addition, to evaluate the effects of curcuminoids on inflammatory response and
oxidative stress after surgery, C‑reactive protein (CRP) and plasma
malondialdehyde (MDA) were assessed preoperatively and postoperatively. The
primary endpoint was the incidence of in-hospital MI.
The groups were
similar at baseline. In-hospital MI was significantly higher in the placebo
group (30.0%) compared with the curcuminoid group (13.1%, P = 0.028). The on-pump
CABG surgical technique was associated with a significantly higher incidence of
MI compared to off-pump surgery (35.5% vs. 6.8%, respectively, P < 0.001). However,
after taking the surgical technique into account, curcuminoid therapy remained an
independent protective factor of in-hospital MI, and on-pump CABG was the
independent predictive factor of in-hospital MI. Also, the incidence of
postoperative left ventricular dysfunction (left ventricular ejection fraction <
40%) was significantly higher in the placebo group than in the curcuminoid group
(25.9% vs. 3.3%, respectively, P = 0.021). The mean increase in CRP and NT-proBNP
levels postoperatively compared to baseline was significantly greater in the
placebo group than in the curcuminoid group (P = 0.031 and P = 0.015,
respectively). Also, the plasma MDA level was increased after surgery in the
placebo group but was decreased significantly after surgery in the curcuminoid
group (P < 0.001). Incidence of drug-related adverse events was not statistically
different between the curcuminoid and placebo groups.
The authors conclude
that curcuminoids significantly decrease the incidence of in-hospital MI after
CABG. In addition, curcuminoids attenuated postoperative NT-proBNP levels and decreased
the incidence of postoperative left ventricular dysfunction. Curcuminoid-associated
decreases in postoperative CRP and MDA levels demonstrate that the effects seen
in this study may be due to the anti-inflammatory and antioxidative effects of
curcuminoids. A limitation of this study was the small sample size. Also, the
authors did not follow the patients to determine the effect of curcuminoids on the
long-term outcome after CABG. These promising results need to be confirmed in
larger studies with a longer patient follow-up. It would be helpful if the
authors could continue the study by contacting the participants or obtaining
their medical records to determine the long-term outcome.
—Heather S. Oliff,
PhD
|